Stockreport

Viela Bio Reports Fourth Quarter and Full Year 2019 Financial Results and Business Highlights

Viela Bio, Inc.  (VIE) 
PDF GAITHERSBURG, Md., March 25, 2020 (GLOBE NEWSWIRE) -- Viela Bio (Nasdaq:VIE), a clinical-stage biotechnology company pioneering treatments for autoimmune and severe in [Read more]